ID   KCC2A_RAT               Reviewed;         478 AA.
AC   P11275;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   02-OCT-2024, entry version 206.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase type II subunit alpha;
DE            Short=CaM kinase II subunit alpha;
DE            Short=CaMK-II subunit alpha;
DE            EC=2.7.11.17 {ECO:0000269|PubMed:11972023};
GN   Name=Camk2a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3475713; DOI=10.1073/pnas.84.16.5962;
RA   Lin C.R., Kapiloff M.S., Durgerian S., Tatemoto K., Russo A.F., Hanson P.,
RA   Schulman H., Rosenfeld M.G.;
RT   "Molecular cloning of a brain-specific calcium/calmodulin-dependent protein
RT   kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:5962-5966(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2856087; DOI=10.1016/0896-6273(88)90210-3;
RA   Bulleit R.F., Bennett M.K., Molloy S.S., Hurley J.B., Kennedy M.B.;
RT   "Conserved and variable regions in the subunits of brain type II
RT   Ca2+/calmodulin-dependent protein kinase.";
RL   Neuron 1:63-72(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 132-327.
RX   PubMed=3037704; DOI=10.1126/science.3037704;
RA   Hanley R.M., Means A.R., Ono T., Kemp B.E., Burgin K.E., Waxham N.,
RA   Kelly P.T.;
RT   "Functional analysis of a complementary DNA for the 50-kilodalton subunit
RT   of calmodulin kinase II.";
RL   Science 237:293-297(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-6.
RX   PubMed=2153289; DOI=10.1073/pnas.87.1.278;
RA   Sunyer T., Sahyoun N.;
RT   "Sequence analysis and DNA-protein interactions within the 5' flanking
RT   region of the Ca2+/calmodulin-dependent protein kinase II alpha-subunit
RT   gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:278-282(1990).
RN   [5]
RP   PROTEIN SEQUENCE OF 231-236; 238-246 AND 461-476, AND INTERACTION WITH
RP   SYN1.
RX   PubMed=1328883; DOI=10.1038/359417a0;
RA   Benfenati F., Valtorta F., Rubenstein J.L., Gorelick F.S., Greengard P.,
RA   Czernik A.J.;
RT   "Synaptic vesicle-associated Ca2+/calmodulin-dependent protein kinase II is
RT   a binding protein for synapsin I.";
RL   Nature 359:417-420(1992).
RN   [6]
RP   PROTEIN SEQUENCE OF 282-299, ACTIVITY REGULATION, AND PHOSPHORYLATION AT
RP   THR-286.
RX   PubMed=2842767; DOI=10.1073/pnas.85.17.6337;
RA   Thiel G., Czernik A.J., Gorelick F., Nairn A.C., Greengard P.;
RT   "Ca2+/calmodulin-dependent protein kinase II: identification of threonine-
RT   286 as the autophosphorylation site in the alpha subunit associated with
RT   the generation of Ca2+-independent activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:6337-6341(1988).
RN   [7]
RP   INTERACTION WITH CAMK2N2.
RX   PubMed=9724800; DOI=10.1073/pnas.95.18.10890;
RA   Chang B.H., Mukherji S., Soderling T.R.;
RT   "Characterization of a calmodulin kinase II inhibitor protein in brain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:10890-10895(1998).
RN   [8]
RP   INTERACTION WITH CAMK2N1.
RX   PubMed=11182241; DOI=10.1016/s0306-4522(00)00520-0;
RA   Chang B.H., Mukherji S., Soderling T.R.;
RT   "Calcium/calmodulin-dependent protein kinase II inhibitor protein:
RT   localization of isoforms in rat brain.";
RL   Neuroscience 102:767-777(2001).
RN   [9]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=11972023; DOI=10.1073/pnas.052159099;
RA   Nair J.S., DaFonseca C.J., Tjernberg A., Sun W., Darnell J.E. Jr.,
RA   Chait B.T., Zhang J.J.;
RT   "Requirement of Ca2+ and CaMKII for Stat1 Ser-727 phosphorylation in
RT   response to IFN-gamma.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:5971-5976(2002).
RN   [10]
RP   INTERACTION WITH SYNGAP1 AND MPDZ, MUTAGENESIS OF 432-ILE--THR-435, AND
RP   FUNCTION.
RX   PubMed=15312654; DOI=10.1016/j.neuron.2004.08.003;
RA   Krapivinsky G., Medina I., Krapivinsky L., Gapon S., Clapham D.E.;
RT   "SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity
RT   and NMDA receptor-dependent synaptic AMPA receptor potentiation.";
RL   Neuron 43:563-574(2004).
RN   [11]
RP   INTERACTION WITH BAALC, AND SUBCELLULAR LOCATION.
RX   PubMed=15659234; DOI=10.1111/j.1471-4159.2004.02902.x;
RA   Wang X., Tian Q.-B., Okano A., Sakagami H., Moon I.S., Kondo H., Endo S.,
RA   Suzuki T.;
RT   "BAALC 1-6-8 protein is targeted to postsynaptic lipid rafts by its N-
RT   terminal myristoylation and palmitoylation, and interacts with a, but not
RT   b, subunit of Ca2+/calmodulin-dependent protein kinase II.";
RL   J. Neurochem. 92:647-659(2005).
RN   [12]
RP   INTERACTION WITH SYNPO2.
RX   PubMed=17923693; DOI=10.1128/mcb.00950-07;
RA   Faul C., Dhume A., Schecter A.D., Mundel P.;
RT   "Protein kinase A, Ca2+/calmodulin-dependent kinase II, and calcineurin
RT   regulate the intracellular trafficking of myopodin between the Z-disc and
RT   the nucleus of cardiac myocytes.";
RL   Mol. Cell. Biol. 27:8215-8227(2007).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-257 AND SER-404, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [14]
RP   PALMITOYLATION.
RX   PubMed=23687301; DOI=10.1074/jbc.m112.431676;
RA   Oku S., Takahashi N., Fukata Y., Fukata M.;
RT   "In silico screening for palmitoyl substrates reveals a role for DHHC1/3/10
RT   (zDHHC1/3/11)-mediated neurochondrin palmitoylation in its targeting to
RT   Rab5-positive endosomes.";
RL   J. Biol. Chem. 288:19816-19829(2013).
CC   -!- FUNCTION: Calcium/calmodulin-dependent protein kinase that functions
CC       autonomously after Ca(2+)/calmodulin-binding and autophosphorylation,
CC       and is involved in various processes, such as synaptic plasticity,
CC       neurotransmitter release and long-term potentiation. Member of the
CC       NMDAR signaling complex in excitatory synapses, it regulates NMDAR-
CC       dependent potentiation of the AMPAR and therefore excitatory synaptic
CC       transmission (PubMed:15312654). Regulates dendritic spine development.
CC       Also regulates the migration of developing neurons. Phosphorylates the
CC       transcription factor FOXO3 to activate its transcriptional activity (By
CC       similarity). Phosphorylates the transcription factor ETS1 in response
CC       to calcium signaling, thereby decreasing ETS1 affinity for DNA (By
CC       similarity). In response to interferon-gamma (IFN-gamma) stimulation,
CC       catalyzes phosphorylation of STAT1, stimulating the JAK-STAT signaling
CC       pathway (PubMed:11972023). In response to interferon-beta (IFN-beta)
CC       stimulation, stimulates the JAK-STAT signaling pathway (By similarity).
CC       Acts as a negative regulator of 2-arachidonoylglycerol (2-AG)-mediated
CC       synaptic signaling via modulation of DAGLA activity (By similarity).
CC       {ECO:0000250|UniProtKB:P11798, ECO:0000250|UniProtKB:Q9UQM7,
CC       ECO:0000269|PubMed:11972023, ECO:0000269|PubMed:15312654}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.17;
CC         Evidence={ECO:0000269|PubMed:11972023};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.17; Evidence={ECO:0000250|UniProtKB:Q9UQM7};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q9UQM7};
CC   -!- ACTIVITY REGULATION: Activated by Ca(2+)/calmodulin. Binding of
CC       calmodulin results in conformational change that relieves intrasteric
CC       autoinhibition and allows autophosphorylation of Thr-286 which turns
CC       the kinase in a constitutively active form and confers to the kinase a
CC       Ca(2+)-independent activity. {ECO:0000269|PubMed:2842767}.
CC   -!- SUBUNIT: There are 4 genes encoding calcium/calmodulin-dependent
CC       protein kinase type II chains: CAMK2A, CAMK2B, CAMK2G and CAMK2D. The
CC       corresponding proteins assemble into homo- or heteromultimeric
CC       holoenzymes composed of 12 subunits with two hexameric rings stacked
CC       one on top of the other (By similarity). Interacts with BAALC
CC       (PubMed:15659234). Interacts with MPDZ (PubMed:15312654). Interacts
CC       with SYN1 (PubMed:1328883). Interacts with CAMK2N2 (PubMed:9724800).
CC       Interacts with SYNGAP1 (PubMed:15312654). Interacts with SYNPO2
CC       (PubMed:17923693). Interacts with SHANK3. Interacts with GRIN2B.
CC       Interacts with CACNB2. Interacts with LRRC7. Interacts with GRM5 (By
CC       similarity). Interacts with DAGLA (via C-terminal); this interaction is
CC       enhanced by autophosphorylation of CAMK2A at Thr-286 (By similarity).
CC       Interacts with CAMK2N1; this interaction requires CAMK2A activation by
CC       Ca(2+) (PubMed:11182241). {ECO:0000250|UniProtKB:P11798,
CC       ECO:0000250|UniProtKB:Q9UQM7, ECO:0000269|PubMed:11182241,
CC       ECO:0000269|PubMed:1328883, ECO:0000269|PubMed:15312654,
CC       ECO:0000269|PubMed:15659234, ECO:0000269|PubMed:17923693,
CC       ECO:0000269|PubMed:9724800}.
CC   -!- INTERACTION:
CC       P11275; P54282: Cacna1a; NbExp=3; IntAct=EBI-2640645, EBI-3507416;
CC       P11275; P08483: Chrm3; NbExp=2; IntAct=EBI-2640645, EBI-7946407;
CC       P11275; P08485: Chrm4; NbExp=10; IntAct=EBI-2640645, EBI-7946147;
CC       P11275; P19490: Gria1; NbExp=3; IntAct=EBI-2640645, EBI-371642;
CC       P11275; Q00960: Grin2b; NbExp=2; IntAct=EBI-2640645, EBI-396905;
CC       P11275; P70587: Lrrc7; NbExp=2; IntAct=EBI-2640645, EBI-7798464;
CC       P11275; P62195: PSMC5; Xeno; NbExp=4; IntAct=EBI-2640645, EBI-357745;
CC   -!- SUBCELLULAR LOCATION: Synapse {ECO:0000269|PubMed:15659234}.
CC       Postsynaptic density {ECO:0000269|PubMed:15659234}. Cell projection,
CC       dendritic spine {ECO:0000250|UniProtKB:Q9UQM7}. Cell projection,
CC       dendrite {ECO:0000250|UniProtKB:Q9UQM7}. Note=Postsynaptic lipid rafts.
CC       {ECO:0000269|PubMed:15659234}.
CC   -!- PTM: Autophosphorylation of Thr-286 following activation by
CC       Ca(2+)/calmodulin. Phosphorylation of Thr-286 locks the kinase into an
CC       activated state. {ECO:0000250|UniProtKB:Q9UQM7}.
CC   -!- PTM: Palmitoylated (PubMed:23687301). Probably palmitoylated by ZDHHC3
CC       and ZDHHC7 (PubMed:23687301). {ECO:0000269|PubMed:23687301}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. CaMK subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J02942; AAA41870.1; -; mRNA.
DR   EMBL; M16960; AAA41855.1; -; mRNA.
DR   EMBL; M29699; AAA40841.1; -; Genomic_DNA.
DR   PIR; A30355; A30355.
DR   RefSeq; NP_037052.1; NM_012920.1.
DR   PDB; 1CDM; X-ray; 2.00 A; B=290-314.
DR   PDB; 1CM1; X-ray; 2.00 A; B=290-314.
DR   PDB; 1CM4; X-ray; 2.00 A; B=290-314.
DR   PDB; 5U6Y; EM; 20.00 A; A/B/C/D/E/F/G/H/I/J/K/L=13-472.
DR   PDBsum; 1CDM; -.
DR   PDBsum; 1CM1; -.
DR   PDBsum; 1CM4; -.
DR   PDBsum; 5U6Y; -.
DR   AlphaFoldDB; P11275; -.
DR   EMDB; EMD-40955; -.
DR   EMDB; EMD-8514; -.
DR   SMR; P11275; -.
DR   BioGRID; 247435; 124.
DR   CORUM; P11275; -.
DR   DIP; DIP-29639N; -.
DR   IntAct; P11275; 21.
DR   MINT; P11275; -.
DR   STRING; 10116.ENSRNOP00000041940; -.
DR   BindingDB; P11275; -.
DR   ChEMBL; CHEMBL2359; -.
DR   GuidetoPHARMACOLOGY; 1555; -.
DR   CarbonylDB; P11275; -.
DR   GlyGen; P11275; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P11275; -.
DR   PhosphoSitePlus; P11275; -.
DR   SwissPalm; P11275; -.
DR   jPOST; P11275; -.
DR   PaxDb; 10116-ENSRNOP00000041940; -.
DR   GeneID; 25400; -.
DR   KEGG; rno:25400; -.
DR   UCSC; RGD:2261; rat.
DR   AGR; RGD:2261; -.
DR   CTD; 815; -.
DR   RGD; 2261; Camk2a.
DR   eggNOG; KOG0033; Eukaryota.
DR   InParanoid; P11275; -.
DR   OrthoDB; 1121238at2759; -.
DR   PhylomeDB; P11275; -.
DR   BRENDA; 2.7.11.17; 5301.
DR   Reactome; R-RNO-3371571; HSF1-dependent transactivation.
DR   Reactome; R-RNO-399719; Trafficking of AMPA receptors.
DR   Reactome; R-RNO-4086398; Ca2+ pathway.
DR   Reactome; R-RNO-438066; Unblocking of NMDA receptors, glutamate binding and activation.
DR   Reactome; R-RNO-5578775; Ion homeostasis.
DR   Reactome; R-RNO-5673000; RAF activation.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-877300; Interferon gamma signaling.
DR   Reactome; R-RNO-936837; Ion transport by P-type ATPases.
DR   EvolutionaryTrace; P11275; -.
DR   PRO; PR:P11275; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0005954; C:calcium- and calmodulin-dependent protein kinase complex; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0032839; C:dendrite cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0043197; C:dendritic spine; ISS:UniProtKB.
DR   GO; GO:0099573; C:glutamatergic postsynaptic density; IDA:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005739; C:mitochondrion; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0099524; C:postsynaptic cytosol; IDA:SynGO.
DR   GO; GO:0014069; C:postsynaptic density; IDA:SynGO.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; IEA:GOC.
DR   GO; GO:0099523; C:presynaptic cytosol; IDA:SynGO.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0009931; F:calcium-dependent protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0005516; F:calmodulin binding; ISO:RGD.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0035254; F:glutamate receptor binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0032794; F:GTPase activating protein binding; IPI:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0016301; F:kinase activity; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0038166; P:angiotensin-activated signaling pathway; ISO:RGD.
DR   GO; GO:0006816; P:calcium ion transport; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0099004; P:calmodulin dependent kinase signaling pathway; IMP:SynGO.
DR   GO; GO:0035458; P:cellular response to interferon-beta; ISS:UniProtKB.
DR   GO; GO:0071346; P:cellular response to type II interferon; ISO:RGD.
DR   GO; GO:0048813; P:dendrite morphogenesis; ISO:RGD.
DR   GO; GO:0060996; P:dendritic spine development; ISS:UniProtKB.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0035235; P:ionotropic glutamate receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0051346; P:negative regulation of hydrolase activity; ISS:UniProtKB.
DR   GO; GO:0098877; P:neurotransmitter receptor transport to plasma membrane; IMP:RGD.
DR   GO; GO:0098989; P:NMDA selective glutamate receptor signaling pathway; IMP:SynGO.
DR   GO; GO:1990443; P:peptidyl-threonine autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0051928; P:positive regulation of calcium ion transport; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0010666; P:positive regulation of cardiac muscle cell apoptotic process; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0046427; P:positive regulation of receptor signaling pathway via JAK-STAT; ISS:UniProtKB.
DR   GO; GO:0098970; P:postsynaptic neurotransmitter receptor diffusion trapping; IMP:SynGO.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:BHF-UCL.
DR   GO; GO:2000124; P:regulation of endocannabinoid signaling pathway; ISS:UniProtKB.
DR   GO; GO:1902108; P:regulation of mitochondrial membrane permeability involved in apoptotic process; ISS:ParkinsonsUK-UCL.
DR   GO; GO:2001222; P:regulation of neuron migration; ISS:UniProtKB.
DR   GO; GO:0048168; P:regulation of neuronal synaptic plasticity; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0098696; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; IDA:SynGO.
DR   GO; GO:0046928; P:regulation of neurotransmitter secretion; ISS:ParkinsonsUK-UCL.
DR   GO; GO:1903076; P:regulation of protein localization to plasma membrane; IGI:ARUK-UCL.
DR   GO; GO:0099148; P:regulation of synaptic vesicle docking; ISO:RGD.
DR   GO; GO:0002931; P:response to ischemia; ISS:ParkinsonsUK-UCL.
DR   CDD; cd14086; STKc_CaMKII; 1.
DR   Gene3D; 3.10.450.50; -; 1.
DR   Gene3D; 6.10.140.620; -; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR013543; Ca/CaM-dep_prot_kinase-assoc.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR032710; NTF2-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24347:SF384; CALCIUM_CALMODULIN-DEPENDENT PROTEIN KINASE TYPE II SUBUNIT ALPHA; 1.
DR   PANTHER; PTHR24347; SERINE/THREONINE-PROTEIN KINASE; 1.
DR   Pfam; PF08332; CaMKII_AD; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF54427; NTF2-like; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Calmodulin-binding; Cell projection;
KW   Direct protein sequencing; Kinase; Lipoprotein; Magnesium; Metal-binding;
KW   Nucleotide-binding; Palmitate; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Synapse; Transferase.
FT   CHAIN           1..478
FT                   /note="Calcium/calmodulin-dependent protein kinase type II
FT                   subunit alpha"
FT                   /id="PRO_0000086094"
FT   DOMAIN          13..271
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          290..300
FT                   /note="Calmodulin-binding"
FT   REGION          310..320
FT                   /note="Interaction with BAALC"
FT                   /evidence="ECO:0000269|PubMed:15659234"
FT   REGION          314..341
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        322..341
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        135
FT                   /note="Proton acceptor"
FT   BINDING         19..27
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         42
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         13
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P11798"
FT   MOD_RES         257
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         286
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:2842767"
FT   MOD_RES         330
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11798"
FT   MOD_RES         331
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11798"
FT   MOD_RES         333
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11798"
FT   MOD_RES         336
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P11798"
FT   MOD_RES         337
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P11798"
FT   MOD_RES         404
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MUTAGEN         432..435
FT                   /note="IRIT->MGTA: Loss of interaction with MPDZ."
FT                   /evidence="ECO:0000269|PubMed:15312654"
FT   CONFLICT        301
FT                   /note="G -> A (in Ref. 3; AAA41855)"
FT                   /evidence="ECO:0000305"
FT   HELIX           295..309
FT                   /evidence="ECO:0007829|PDB:1CDM"
SQ   SEQUENCE   478 AA;  54115 MW;  306F416CCE9B5F62 CRC64;
     MATITCTRFT EEYQLFEELG KGAFSVVRRC VKVLAGQEYA AKIINTKKLS ARDHQKLERE
     ARICRLLKHP NIVRLHDSIS EEGHHYLIFD LVTGGELFED IVAREYYSEA DASHCIQQIL
     EAVLHCHQMG VVHRDLKPEN LLLASKLKGA AVKLADFGLA IEVEGEQQAW FGFAGTPGYL
     SPEVLRKDPY GKPVDLWACG VILYILLVGY PPFWDEDQHR LYQQIKAGAY DFPSPEWDTV
     TPEAKDLINK MLTINPSKRI TAAEALKHPW ISHRSTVASC MHRQETVDCL KKFNARRKLK
     GAILTTMLAT RNFSGGKSGG NKKNDGVKES SESTNTTIED EDTKVRKQEI IKVTEQLIEA
     ISNGDFESYT KMCDPGMTAF EPEALGNLVE GLDFHRFYFE NLWSRNSKPV HTTILNPHIH
     LMGDESACIA YIRITQYLDA GGIPRTAQSE ETRVWHRRDG KWQIVHFHRS GAPSVLPH
//
